login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
X4 PHARMACEUTICALS INC (XFOR) Stock News
USA
- NASDAQ:XFOR -
US98420X2027
-
Common Stock
3.71
USD
+0.21 (+5.85%)
Last: 11/7/2025, 8:00:02 PM
3.337
USD
-0.37 (-10.05%)
After Hours:
11/7/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
XFOR Latest News, Press Relases and Analysis
All
Press Releases
17 days ago - By: Chartmill
- Mentions:
DECK
MOFG
QLGN
INBX
...
Which stocks are gapping on Friday?
4 days ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals to Participate in Guggenheim’s Second Annual Healthcare Innovation Conference
4 days ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals to Participate in Guggenheim’s Second Annual Healthcare Innovation Conference
5 days ago - By: Zacks Investment Research
- Mentions:
MGTX
MeiraGTx Holdings PLC (MGTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
5 days ago - By: Zacks Investment Research
- Mentions:
ALVO
X4 Pharmaceuticals (XFOR) Reports Q3 Loss, Misses Revenue Estimates
5 days ago - By: Zacks Investment Research
- Mentions:
TECH
Techne (TECH) Meets Q1 Earnings Estimates
5 days ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
13 days ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million
13 days ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million
17 days ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering
17 days ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering
17 days ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals Announces Proposed Underwritten Public Offering
17 days ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals Announces Proposed Underwritten Public Offering
2 months ago - By: Stocktwits
X4 Pharma To Halve Headcount Amid Efforts To Complete Neutropenia Trial
2 months ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation
2 months ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation
3 months ago - By: Benzinga
- Mentions:
SNGX
VKTX
PPCB
TELA
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
3 months ago - By: Benzinga
- Mentions:
IBIO
SNGX
LIXT
ALTS
...
12 Health Care Stocks Moving In Monday's After-Market Session
3 months ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Stocktwits
- Mentions:
VTWG
URTY
X4 Pharmaceuticals Stock Rises On Closing Of Upsized Offering, But Brokerage Lowers Price Target
3 months ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
3 months ago - By: X4 Pharmaceuticals
X4 Pharmaceuticals Announces $60 Million Equity Financing with Concurrent Changes in Management and Board Leadership
Please enable JavaScript to continue using this application.